Thursday, October 17, 2024

Take your QIAGEN Ingenuity Pathway Analysis (IPA) analyses to the next level by comparing them to your own analyses (different...

Thursday, October 17, 2024

In this 90-minute training, you'll learn how to perform drug treatment, toxicology and target safety assessment-related discoveries using QIAGEN Ingenuity...

Thursday, October 17, 2024

Join us for a 120-minute training session for new users of QIAGEN IPA. Users will learn how to: • Upload...

Thursday, October 17, 2024

QIAGEN Ingenuity Pathway Analysis (IPA) represents a robust resource to aid in the process of writing grants publications. Driven by...

Thursday, October 17, 2024

Environmental contamination of perfluoroalkyl and polyfluoroalkyl substances (PFAS) is of significant concern due to a wide range of adverse health...

Thursday, October 17, 2024

Potencialize suas análises e interpretação de dados com o IPA: User-Case Nesse webinar, a Dr. Ludmila Ferreira mostrará como utilizou...

Thursday, October 17, 2024

As requested by many users, your QIAGEN Digital Insights team is excited to introduce QIAGEN Ingenuity Pathway Analysis (IPA) deep-dive...

Thursday, October 17, 2024

Join us for a 60-minute training session for new users of QIAGEN IPA. Users will learn how to: • Upload...

Thursday, October 17, 2024

Discovering new genes implicated in hereditary diseases or cancer progression is challenging yet advancing rapidly due to the increase in...

Thursday, October 17, 2024

Some human studies may be unfeasible or unethical, making cross-species research critical for drug discovery and biomarker validation. Cross-species research...

Sample to Insight
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.